This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Lifearc. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Kayleigh Webb-Smith: Innovator in Pharmaceutical Research
Introduction
Kayleigh Webb-Smith is a prominent inventor based in London, GB. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target various diseases. With a total of 2 patents, her work is paving the way for innovative treatments.
Latest Patents
Kayleigh's latest patents include the invention of fused thiazolopyrimidine derivatives as MNKs inhibitors. These compounds are designed to address diseases characterized by uncontrolled cell growth, proliferation, and survival. The invention also encompasses pharmaceutical compositions and therapeutic uses of these compounds, particularly in treating neurodegenerative disorders such as Alzheimer's disease.
Career Highlights
Kayleigh is currently employed at LifeArc, where she continues to advance her research and development efforts. Her work is instrumental in creating new therapeutic options for patients suffering from various medical conditions.
Collaborations
Kayleigh collaborates with notable colleagues, including Jon James Winter-Holt and Edward Giles Mciver. These partnerships enhance her research capabilities and contribute to the innovative environment at LifeArc.
Conclusion
Kayleigh Webb-Smith is a dedicated inventor whose work in pharmaceutical research is making a significant impact. Her innovative patents and collaborations are essential in the fight against debilitating diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile